As of 1:16pm ET
| -0.125 / -3.23%|
The 4 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +6.67% increase from the last price of 3.75.
The current consensus among 5 polled investment analysts is to Hold stock in aTyr Pharma Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.